Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Ibrahim A. Hanouneh, Naim Alkhouri, Amit G. Singal
Clin Mol Hepatol. 2019;25(3):264-269.   Published online 2019 Mar 4     DOI: https://doi.org/10.3350/cmh.2019.1001
Citations to this article as recorded by Crossref logo
Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?
Neehar D. Parikh, Nabihah Tayob, Amit G. Singal
Journal of Hepatology.2023; 78(1): 207.     CrossRef
KRT17 serves as an oncogene biomarker of poor survival in patients with hepatocellular carcinoma
Jing-Lin Wang, Lu Zhang, Chen-Zhuo Xu, Xue-Qian Qin, Shu-Jun Liu, Bao-Jie Wen, Hao-Zhen Ren
Biomedical Technology.2023; 3: 18.     CrossRef
Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chan
Clinical and Molecular Hepatology.2023; 29(2): 277.     CrossRef
Should we undertake surveillance for HCC in patients with MAFLD?
Blanca Norero, Jean-François Dufour
Therapeutic Advances in Endocrinology and Metabolism.2023; 14: 204201882311603.     CrossRef
Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
Yi-Te Lee, Mohammad A. Karim, Hye Chung Kum, Sulki Park, Nicole E. Rich, Mazen Noureddin, Amit G. Singal, Ju Dong Yang
Clinical and Molecular Hepatology.2023; 29(2): 453.     CrossRef
Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis
Daniel Q. Huang, Nobuharu Tamaki, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Hye Won Lee, Seng Gee Lim, Tae Seop Lim, Masayuki Kurosaki, Hiroyuki Marusawa, Toshie Mashiba, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Namiki Izumi,
Hepatology.2023; 77(5): 1746.     CrossRef
Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis
Jaideep Behari, Amir Gougol, Renwei Wang, Hung N. Luu, Pedram Paragomi, Yi-Chuan Yu, Michele Molinari, Kapil Chopra, Shahid M. Malik, David Geller, Jian-Min Yuan
Hepatology Communications.2023;[Epub]     CrossRef
A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B
Hye Won Lee, Hwiyoung Kim, Taeyun Park, Soo Young Park, Young Eun Chon, Yeon Seok Seo, Jae Seung Lee, Jun Yong park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
Liver International.2023; 43(8): 1813.     CrossRef
Risk factors and prevention of liver cancer: A bibliometric and visual analysis
Min Yang, Huiqin Zhang, Jieqiu Zhang, Xiaopeng Yao
Medicine.2023; 102(47): e35740.     CrossRef
Comparative long‐term outcomes of laparoscopic hepatectomy and radiofrequency ablation for hepatocellular carcinoma located in the anterolateral segments of the liver
Sungho Kim, Chang Jin Yoon, Jai Young Cho, Ho‐Seong Han, Yoo‐Seok Yoon, Hae Won Lee, Jun Suh Lee, Moonhwan Kim, Boram Lee, Soyeon Ahn
Journal of Hepato-Biliary-Pancreatic Sciences.2022; 29(3): 349.     CrossRef
Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL
Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
American Journal of Gastroenterology.2022; 117(2): 288.     CrossRef
Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B
Ho Soo Chun, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Digestive Diseases and Sciences.2022; 67(7): 3412.     CrossRef
Changes in general and central fatness are associated with hepatocellular carcinoma: A Korean nationwide longitudinal study
Mi Na Kim, Kyungdo Han, Juhwan Yoo, Yeonjung Ha, Young Eun Chon, Ju Ho Lee, Seong Gyu Hwang
International Journal of Cancer.2022; 150(10): 1587.     CrossRef
Achievement of textbook outcomes and comparisons with benchmark values after laparoscopic left lateral sectionectomy
Mizelle D’Silva, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonhwan Kim
Updates in Surgery.2022; 74(4): 1299.     CrossRef
Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma
Hyo Jung Cho, Young Hwan Ahn, Min Suh Sim, Jung Woo Eun, Soon Sun Kim, Bong Wan Kim, Jimi Huh, Jei Hee Lee, Jai Keun Kim, Buil Lee, Jae Youn Cheong, Bohyun Kim
Gut and Liver.2022; 16(2): 277.     CrossRef
Better survival of patients with hepatitis B virus-related hepatocellular carcinoma in South Korea: Changes in 16-years cohorts
Sang Il Choi, Yuri Cho, Moran Ki, Bo Hyun Kim, In Joon Lee, Tae Hyun Kim, Seong Hoon Kim, Young Hwan Koh, Hyun Beom Kim, Eun Kyung Hong, Chang-Min Kim, Joong-Won Park, Hamidreza Karimi-Sari
PLOS ONE.2022; 17(3): e0265668.     CrossRef
Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study
Ha Il Kim, Jihyun An, Ji Yoon Kim, Hyun Phil Shin, Seo Young Park, Gi-Won Song, Han Chu Lee, Ju Hyun Shim
Liver Cancer.2022; 11(2): 141.     CrossRef
Deubiquitylating Enzyme OTUB2 Promotes the Progress of Liver Cancer Cells by Stabilizing TRIM54
An Wang, Xiaofeng Chen, Dongen Li, Liang Yang, Jianshuai Jiang
International Journal of Pharmacology.2022; 18(4): 633.     CrossRef
Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify
Philip J. Johnson, Hamish Innes, David M. Hughes, Anton Kalyuzhnyy, Takashi Kumada, Hidenori Toyoda
British Journal of Cancer.2022; 127(7): 1263.     CrossRef
Applications of molecular barcode sequencing for the detection of low‐frequency variants in circulating tumour DNA from hepatocellular carcinoma
Hye Won Lee, Esl Kim, Kyung Joo Cho, Hye Jung Park, Jieun Seo, Hyeonah Lee, Eunha Baek, Jong Rak Choi, Kwang‐Hyub Han, Seung‐Tae Lee, Jun Yong Park
Liver International.2022; 42(10): 2317.     CrossRef
Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease
Won Sohn, Danbee Kang, Minwoong Kang, Eliseo Guallar, Juhee Cho, Yong-Han Paik
Clinical and Molecular Hepatology.2022; 28(4): 851.     CrossRef
Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
Young-Hwan Ahn, Heirim Lee, Ji Eun Han, Hyo Jung Cho, Jae Youn Cheong, Bumhee Park, Soon Sun Kim
Journal of Liver Cancer.2022; 22(2): 125.     CrossRef
Factors associated with nonadherence to surveillance for hepatocellular carcinoma among patients with hepatic C virus cirrhosis, 2000–2015
Shen-Shong Chang, Hsiao-Yun Hu, Feng-Shiang Cheng, Yu-Chin Chen, Yung-Feng Yen, Nicole Huang
Medicine.2022; 101(47): e31907.     CrossRef
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir
Jin Won Chang, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Yu Rim Lee, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Soo Young Park, Seung Up Kim
Journal of Viral Hepatitis.2021; 28(1): 95.     CrossRef
Improved Outcomes of Laparoscopic Liver Resection for Hepatocellular Carcinoma Located in Posterosuperior Segments of the Liver
Yujin Kwon, Jai Young Cho, Ho‐Seong Han, Yoo‐Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonwhan Kim
World Journal of Surgery.2021; 45(4): 1178.     CrossRef
Metabolic disease as a risk of hepatocellular carcinoma
Naoshi Nishida
Clinical and Molecular Hepatology.2021; 27(1): 87.     CrossRef
Addition of liver stiffness enhances the predictive accuracy of the PAGE‐B model for hepatitis B‐related hepatocellular carcinoma
Hye Yeon Chon, Han Ah Lee, Sang Jun Suh, Jung Il Lee, Byung Seok Kim, In Hee Kim, Chang Hyeong Lee, Byoung Kuk Jang, Hyun Woong Lee, Jae Seok Hwang, Chang Hun Lee, Jin‐Woo Lee, Jung Hwan Yu, Yeon Seok Seo, Hyung Joon Yim, Seung Up Kim
Alimentary Pharmacology & Therapeutics.2021; 53(8): 919.     CrossRef
Validation of the HCC‐RESCUE score to predict hepatocellular carcinoma risk in Caucasian chronic hepatitis B patients under entecavir or tenofovir therapy
Fatih Güzelbulut, Pınar Gökçen, Güray Can, Gupse Adalı, Ayça Gökçen Değirmenci Saltürk, Özgür Bahadır, Kamil Özdil, Hamdi Levent Doğanay
Journal of Viral Hepatitis.2021; 28(5): 826.     CrossRef
The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Hepatocellular Carcinoma.2021; Volume 8: 467.     CrossRef
Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B
Hye Yeon Chon, Yeon Seok Seo, Jung il Lee, Byung Seok Kim, Byoung Kuk Jang, Sang Gyune Kim, Ki Tae Suk, In Hee Kim, Jin-Woo Lee, Young Eun Chon, Moon Young Kim, Soung Won Jeong, Han Ah Lee, Sun Young Yim, Soon Ho Um, Hyun Woong Lee, Kwan Sik Lee, Jeong Eu
European Journal of Gastroenterology & Hepatology.2021; 33(6): 885.     CrossRef
External validation of hepatocellular carcinoma risk scores in patients with chronic hepatitis B virus infection in China
Tao Lou, Bin Li, Pian Xiong, Caiting Jin, Yagang Chen
Journal of Viral Hepatitis.2021; 28(10): 1373.     CrossRef
External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Viral Hepatitis.2021; 28(6): 951.     CrossRef
An MRI-guided targeting dual-responsive drug delivery system for liver cancer therapy
Weihe Yao, Chenyu Liu, Ning Wang, Hengjun Zhou, Hailiang Chen, Weihong Qiao
Journal of Colloid and Interface Science.2021; 603: 783.     CrossRef
Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
Han Ah Lee, Young-Sun Lee, Beom Kyung Kim, Young Kul Jung, Seung Up Kim, Jun Yong Park, Ji Hoon Kim, Hyunggin An, Do Young Kim, Hyung Joon Yim, Sang Hoon Ahn, Jong Eun Yeon, Kwan Soo Byun, Kwang-Hyub Han, Soon Ho Um, Yeon Seok Seo
Gut and Liver.2021; 15(3): 420.     CrossRef
Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma
Fuan Wang, Chuan Xu, Guiling Li, Penghua Lv, Jianping Gu
Experimental Cell Research.2021; 409(2): 112910.     CrossRef
Factors Associated with Poor Self-Rated Health in Cancer Patients
Hyo Rim Ju, Ye Rim Jeon, Seo Young Kang, Jung Ah Lee, Young Sik Kim
Korean Journal of Family Practice.2021; 11(5): 385.     CrossRef
Expression and clinical significance of BDH1 in liver cancer
Zhicheng Liu, Yanqing Li, Ying Liu, Dingquan Yang, Yan Jiao, Yunpeng Liu
Medicine.2021; 100(48): e28013.     CrossRef
Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
Soon Kyu Lee, Sung Won Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
International Journal of Molecular Sciences.2021; 22(19): 10271.     CrossRef
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
International Journal of Molecular Sciences.2021; 22(18): 10027.     CrossRef
Reply to: “Comment on – A multi-center study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in the Republic of Korea”
Beom Kyung Kim
Journal of Hepatology.2020; 72(1): 198.     CrossRef
Clinical characteristics and prognostic value of MEX3A mRNA in liver cancer
Dingquan Yang, Yan Jiao, Yanqing Li, Xuedong Fang
PeerJ.2020; 8: e8252.     CrossRef
Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation
Byung-Yoon Yun, Hye Won Lee, In Kyung Min, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Cancers.2020; 12(9): 2527.     CrossRef
Improved outcomes of major laparoscopic liver resection for hepatocellular carcinoma
Hyo Jun Kim, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Junyub Kim
Surgical Oncology.2020; 35: 470.     CrossRef
New advances in the diagnosis and management of hepatocellular carcinoma
Ju Dong Yang, Julie K Heimbach
BMJ.2020; : m3544.     CrossRef
Reactive oxygen species-induced activation of Yes-associated protein-1 through the c-Myc pathway is a therapeutic target in hepatocellular carcinoma
Yuri Cho, Min Ji Park, Koeun Kim, Sun Woong Kim, Wonjin Kim, Sooyeon Oh, Joo Ho Lee
World Journal of Gastroenterology.2020; 26(42): 6599.     CrossRef
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
Hye Won Lee, Dai Hoon Han, Hye Jung Shin, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Cancers.2020; 12(11): 3414.     CrossRef
Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
Jun Sik Yoon, Byeong Geun Song, Jeong-Hoon Lee, Hyo Young Lee, Sun Woong Kim, Young Chang, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Dong Hyun Sinn, Yoon Jun Kim, Joon Hyeok Lee, Jung-Hwan Yoon
BMC Cancer.2019;[Epub]     CrossRef